CN111686194A - Chinese herbal medicine for adjuvant therapy of diabetes and preparation method thereof - Google Patents
Chinese herbal medicine for adjuvant therapy of diabetes and preparation method thereof Download PDFInfo
- Publication number
- CN111686194A CN111686194A CN201910381969.0A CN201910381969A CN111686194A CN 111686194 A CN111686194 A CN 111686194A CN 201910381969 A CN201910381969 A CN 201910381969A CN 111686194 A CN111686194 A CN 111686194A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese herbal
- herbal medicine
- adjuvant therapy
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000411851 herbal medicine Species 0.000 title claims abstract description 43
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 40
- 238000009098 adjuvant therapy Methods 0.000 title claims abstract description 30
- 238000002360 preparation method Methods 0.000 title claims abstract description 25
- 239000003814 drug Substances 0.000 claims abstract description 46
- 239000002994 raw material Substances 0.000 claims abstract description 23
- 244000130270 Fagopyrum tataricum Species 0.000 claims abstract description 21
- 235000014693 Fagopyrum tataricum Nutrition 0.000 claims abstract description 21
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 21
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract description 13
- 244000111489 Gardenia augusta Species 0.000 claims abstract description 11
- 240000000249 Morus alba Species 0.000 claims abstract description 11
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 11
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 11
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 11
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims abstract description 11
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims abstract description 11
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 11
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 11
- 244000241838 Lycium barbarum Species 0.000 claims abstract description 10
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 10
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 10
- 238000000034 method Methods 0.000 claims abstract description 8
- 239000007788 liquid Substances 0.000 claims description 44
- 239000000203 mixture Substances 0.000 claims description 32
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 26
- 238000001914 filtration Methods 0.000 claims description 20
- 239000002245 particle Substances 0.000 claims description 19
- 238000009835 boiling Methods 0.000 claims description 15
- 239000008187 granular material Substances 0.000 claims description 12
- 239000008213 purified water Substances 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 10
- 229910001220 stainless steel Inorganic materials 0.000 claims description 10
- 239000010935 stainless steel Substances 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 9
- 230000005484 gravity Effects 0.000 claims description 7
- 238000010438 heat treatment Methods 0.000 claims description 7
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 claims description 5
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 claims description 5
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 5
- 239000001814 pectin Substances 0.000 claims description 5
- 235000010987 pectin Nutrition 0.000 claims description 5
- 229920001277 pectin Polymers 0.000 claims description 5
- 230000005855 radiation Effects 0.000 claims description 5
- 238000007789 sealing Methods 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 238000005303 weighing Methods 0.000 claims description 5
- 239000000811 xylitol Substances 0.000 claims description 5
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 5
- 229960002675 xylitol Drugs 0.000 claims description 5
- 235000010447 xylitol Nutrition 0.000 claims description 5
- 239000002671 adjuvant Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 19
- 239000008280 blood Substances 0.000 abstract description 17
- 210000004369 blood Anatomy 0.000 abstract description 17
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract description 14
- 102000004877 Insulin Human genes 0.000 abstract description 7
- 108090001061 Insulin Proteins 0.000 abstract description 7
- 229940125396 insulin Drugs 0.000 abstract description 7
- 230000001737 promoting effect Effects 0.000 abstract description 7
- 229940079593 drug Drugs 0.000 abstract description 5
- 230000001105 regulatory effect Effects 0.000 abstract description 5
- 230000036772 blood pressure Effects 0.000 abstract description 4
- 244000269722 Thea sinensis Species 0.000 abstract description 3
- 230000017531 blood circulation Effects 0.000 abstract description 3
- 230000023852 carbohydrate metabolic process Effects 0.000 abstract description 3
- 150000002632 lipids Chemical class 0.000 abstract description 3
- 210000004185 liver Anatomy 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 5
- 210000002216 heart Anatomy 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 239000002398 materia medica Substances 0.000 description 5
- 241000219051 Fagopyrum Species 0.000 description 4
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 4
- 235000013325 dietary fiber Nutrition 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 230000007935 neutral effect Effects 0.000 description 4
- 239000006187 pill Substances 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 2
- 206010059866 Drug resistance Diseases 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 235000017784 Mespilus germanica Nutrition 0.000 description 2
- 244000182216 Mimusops elengi Species 0.000 description 2
- 235000000560 Mimusops elengi Nutrition 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 2
- 235000007837 Vangueria infausta Nutrition 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 229940126678 chinese medicines Drugs 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 150000002212 flavone derivatives Chemical class 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000003914 insulin secretion Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 229940126673 western medicines Drugs 0.000 description 2
- 239000005541 ACE inhibitor Substances 0.000 description 1
- 229940077274 Alpha glucosidase inhibitor Drugs 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 229940123208 Biguanide Drugs 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- 102000051325 Glucagon Human genes 0.000 description 1
- 108060003199 Glucagon Proteins 0.000 description 1
- 241000257303 Hymenoptera Species 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010023379 Ketoacidosis Diseases 0.000 description 1
- 208000007976 Ketosis Diseases 0.000 description 1
- 206010024419 Libido decreased Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000180649 Panax notoginseng Species 0.000 description 1
- 235000003143 Panax notoginseng Nutrition 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000017442 Retinal disease Diseases 0.000 description 1
- 206010038923 Retinopathy Diseases 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- 229940100389 Sulfonylurea Drugs 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 239000003888 alpha glucosidase inhibitor Substances 0.000 description 1
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 150000004283 biguanides Chemical class 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
- 229960004666 glucagon Drugs 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 208000022530 polyphagia Diseases 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 208000026451 salivation Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Alternative & Traditional Medicine (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Chinese herbal medicine for adjuvant therapy of diabetes and a preparation method thereof, belonging to the field of Chinese herbal medicine preparation. The Chinese herbal medicine for adjuvant therapy of diabetes is characterized by comprising the following raw materials in parts by weight: 36-40 parts of pseudo-ginseng stem leaves, 12-16 parts of gardenia fruits, 1-3 parts of wolfberry fruits, 1-3 parts of rhizoma polygonati, 2-4 parts of lotus leaves, 2-4 parts of mulberry leaves, 12-16 parts of kudzu roots and 17-21 parts of tartary buckwheat; the invention utilizes the compatibility of the components of the Chinese herbal medicines to effectively activate the inert insulin, so that the inert insulin recovers the activity and participates in the normal glycometabolism process; the raw materials are rich, and the health-care tea has the effects of tonifying qi, nourishing yin, reducing blood sugar, regulating lipid, reducing blood pressure, and promoting blood circulation to remove blood stasis; compared with other Chinese herbal medicines in the prior art, the Chinese herbal medicine has a simple formula, does not contain rare medicines, has low cost and can greatly reduce the economic burden of patients and families.
Description
Technical Field
The invention relates to the technical field of Chinese herbal medicine preparation, in particular to a Chinese herbal medicine for adjuvant therapy of diabetes and a preparation method thereof.
Background
Diabetes is a relatively common endocrine-metabolic disease. The disease is mainly caused by insufficient insulin secretion and inappropriately excessive glucagon secretion. The traditional Chinese medicine is called as diabetes, the typical symptoms of polyphagia, polydipsia, diuresis and emaciation of body form are caused by deficiency of yin of patients and weakness of five internal organs, the general symptoms of the diabetes are lumbago, soreness and pain of limbs, feelings of ants, numbness, skin pruritus and hyposexuality, serious patients can be complicated with heart, kidney and retinopathy, and ketoacidosis can be caused to cause coma and death.
At present, western medicine therapy is mostly adopted for treating diabetes, mainly comprising insulin secretion promoters, alpha-glucosidase inhibitors, growth factor antagonists, angiotensin converting enzyme inhibitors and the like, such as insulin, biguanides, sulfonylureas and the like, but the western medicine has certain limitation and larger side effect, has larger damage to liver and kidney after long-term administration, is easy to generate drug resistance, and is difficult to fundamentally treat the diabetes. Therefore, it is the focus of research to find a traditional Chinese medicine for treating diabetes, which has better effect, can be used for a long time and has small side effect.
Disclosure of Invention
The invention aims to solve the problems that Chinese and western medicines in the prior art have certain limitation and large side effect, and the Chinese and western medicines have large damage to the liver and the kidney and are easy to generate drug resistance after being taken for a long time and are difficult to fundamentally treat diabetes, and provides a Chinese herbal medicine for adjuvant therapy of diabetes and a preparation method thereof.
In order to achieve the purpose, the invention adopts the following technical scheme:
the Chinese herbal medicine for adjuvant therapy of diabetes is characterized by comprising the following raw materials in parts by weight: 31-45 parts of pseudo-ginseng stem leaves, 7-21 parts of gardenia fruits, 0.5-4 parts of wolfberry fruits, 0.5-4 parts of rhizoma polygonati, 1-7 parts of lotus leaves, 1-6.5 parts of mulberry leaves, 7-21 parts of kudzu roots and 12-26 parts of tartary buckwheat.
Preferably, the Chinese herbal medicine for adjuvant therapy of diabetes is characterized by comprising the following raw materials in parts by weight: 36-40 parts of pseudo-ginseng stem leaves, 12-16 parts of gardenia fruits, 1-3 parts of wolfberry fruits, 1-3 parts of rhizoma polygonati, 2-4 parts of lotus leaves, 2-4 parts of mulberry leaves, 12-16 parts of kudzu roots and 17-21 parts of tartary buckwheat.
Preferably, the Chinese herbal medicine for adjuvant therapy of diabetes is characterized by comprising the following raw materials in parts by weight: 38 parts of pseudo-ginseng stem leaves, 14 parts of gardenia fruits, 2 parts of wolfberry fruits, 2 parts of rhizoma polygonati, 3 parts of lotus leaves, 3 parts of mulberry leaves, 14 parts of kudzu roots and 19 parts of tartary buckwheat.
Preferably, the Chinese herbal medicine for adjuvant therapy of diabetes and the preparation method thereof are characterized in that the preparation method comprises the following steps:
the method comprises the following steps: weighing the raw materials according to a given proportion, pouring the raw materials into a boiling and extracting pot, and adding purified water with the weight 6-12 times of that of the medicinal materials.
Step two: boiling with strong fire, decocting with slow fire for 0.5-5 hr, and filtering to obtain medicinal liquid a.
Step three: adding 6-12 times of purified water into the residue, boiling, decocting with slow fire for 0.5-5 hr, and filtering to obtain medicinal liquid b.
Step four: mixing the liquid medicine a and the liquid medicine b, and filtering the mixture through a 100-mesh stainless steel screen to obtain liquid medicine c.
Step five: concentrating the liquid medicine c in a concentration tank to a relative specific gravity of 1.10-1.30g/ml, and filtering with a 230-mesh stainless steel filter screen to obtain liquid medicine d.
Step six: and adding auxiliary materials into the liquid medicine d, mixing and stirring for 15 minutes to obtain a mixture e.
Step seven: and (3) putting the mixture e into a drying box, setting the temperature to be 50-60 ℃, and keeping the water content to be less than 10% after 12 hours to obtain a mixture f.
Step eight: and (3) placing the mixture f into an ultramicro crusher, and crushing the mixture f into particles g with the particle size of less than 0.1 micrometer.
Step nine: and (3) carrying out microwave irradiation heating on the particles g to promote the oil-containing cells to be fully cracked and reduce the water content to 4-8%.
Step ten: and granulating the irradiated granules g, bagging and sealing to obtain the radiation-resistant granules.
Preferably, purified water with the amount 9 times that of the medicinal materials is added in the first step and the third step.
Preferably, the second step and the third step are boiled for 2 hours by slow fire.
Preferably, the liquid medicine c in the fifth step is concentrated to the relative specific gravity of 1.180-1.200 g/ml.
Preferably, the auxiliary materials in the sixth step are one or more of pectin, EGCG, xylitol and edible essence.
Preferably, in the step eight, the mixture f is micronized to form particles g with a particle size of about 0.01 microns.
Preferably, the water content is reduced to 6% in the ninth step.
Compared with the prior art, the invention provides a Chinese herbal medicine for adjuvant therapy of diabetes and a preparation method thereof, and the Chinese herbal medicine has the following beneficial effects:
1. the Chinese herbal medicine for adjuvant therapy of diabetes has the functions of resisting oxidation and enhancing human immunity by adding tartary buckwheat; the tartary buckwheat can effectively reduce hypertension, hyperlipidemia and hyperglycemia; can remove in vivo waste, improve heart and brain circulation, relieve fatigue, and recover energy; the tartary buckwheat contains a large amount of coarse grain dietary fibers, so that the antioxidation function of the skin can be increased, the skin is healthy and glossy, and the beauty is maintained; the buckwheat flavone contained in the buckwheat can effectively prevent and treat diabetes; the tartary buckwheat contains rare coarse food grain dietary fiber, so that the distribution of gastrointestinal nutrition can be balanced, and constipation can be effectively treated.
2. The Chinese herbal medicine for adjuvant therapy of diabetes is added with auxiliary materials, so that liquid medicine can be easily prepared into decoction, granules, tablets, pills, capsules or dripping pills, and the required preparation types are prepared according to the requirements of users.
3. The Chinese herbal medicine for the adjuvant treatment of diabetes promotes the oil-containing cells to be fully cracked by microwave irradiation heating, so that the water content of the oil-containing cells is reduced to 6%, the medicine property is improved, and the possibility of overdue medicine is reduced.
The invention utilizes the compatibility among each component of Chinese herbal medicine, effectively activates the inert insulin, leads the inert insulin to recover the activity and participate in the normal glycometabolism process; the raw materials are rich, and the health-care tea has the effects of tonifying qi, nourishing yin, reducing blood sugar, regulating lipid, reducing blood pressure, and promoting blood circulation to remove blood stasis; compared with other Chinese herbal medicines in the prior art, the Chinese herbal medicine has a simple formula, does not contain rare medicines, has low cost and can greatly reduce the economic burden of patients and families.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all embodiments.
In the description of the present invention, it is to be understood that the terms "upper", "lower", "front", "rear", "left", "right", "top", "bottom", "inner", "outer", and the like, indicate orientations and positional relationships only for convenience in describing the present invention and simplifying the description, but do not indicate or imply that the device or element being referred to must have a particular orientation, be constructed and operated in a particular orientation, and thus, should not be construed as limiting the present invention.
Example 1:
the Chinese herbal medicine for adjuvant therapy of diabetes is characterized by comprising the following raw materials in parts by weight: 31 parts of pseudo-ginseng stem leaves, 7 parts of gardenia fruits, 0.5 part of wolfberry fruits, 0.5 part of rhizoma polygonati, 1 part of lotus leaves, 1 part of mulberry leaves, 7 parts of kudzu roots and 12 parts of tartary buckwheat.
The Chinese herbal medicine for adjuvant therapy of diabetes and the preparation method thereof are characterized in that the preparation method comprises the following steps:
the method comprises the following steps: weighing the raw materials according to the formula in a given proportion, pouring the raw materials into a boiling and extracting pot, and adding 9 times of purified water.
Step two: boiling with strong fire, decocting with slow fire for 2 hr, and filtering to obtain medicinal liquid a.
Step three: adding 9 times of purified water into the residue, boiling, decocting with slow fire for 2 hr, and filtering to obtain medicinal liquid b.
Step four: mixing the liquid medicine a and the liquid medicine b, and filtering the mixture through a 100-mesh stainless steel screen to obtain liquid medicine c.
Step five: concentrating the liquid medicine c in a concentration tank to a relative specific gravity of 1.180-1.200g/ml, and filtering with a 230-mesh stainless steel filter screen to obtain liquid medicine d.
Step six: and adding one or more of pectin, EGCG, xylitol and edible essence into the liquid medicine d, and mixing and stirring for 15 minutes to obtain a mixture e.
Step seven: and (3) putting the mixture e into a drying box, setting the temperature to be 50-60 ℃, and keeping the water content to be less than 10% after 12 hours to obtain a mixture f.
Step eight: and (3) placing the mixture f into an ultramicro crusher, and crushing the mixture f into particles g with the particle size of less than 0.01 micrometer.
Step nine: and (3) carrying out microwave irradiation heating on the particles g to promote the oil-containing cells to be fully cracked, so that the water content of the oil-containing cells is reduced to 6%.
Step ten: and granulating the irradiated granules g, bagging and sealing to obtain the radiation-resistant granules.
Example 2:
the Chinese herbal medicine for adjuvant therapy of diabetes is characterized by comprising the following raw materials in parts by weight: 45 parts of pseudo-ginseng stem leaves, 21 parts of gardenia fruits, 4 parts of wolfberry fruits, 4 parts of rhizoma polygonati, 7 parts of lotus leaves, 6.5 parts of mulberry leaves, 21 parts of kudzu roots and 26 parts of tartary buckwheat.
The Chinese herbal medicine for adjuvant therapy of diabetes and the preparation method thereof are characterized in that the preparation method comprises the following steps:
the method comprises the following steps: weighing the raw materials according to the formula in a given proportion, pouring the raw materials into a boiling and extracting pot, and adding 9 times of purified water.
Step two: boiling with strong fire, decocting with slow fire for 2 hr, and filtering to obtain medicinal liquid a.
Step three: adding 9 times of purified water into the residue, boiling, decocting with slow fire for 2 hr, and filtering to obtain medicinal liquid b.
Step four: mixing the liquid medicine a and the liquid medicine b, and filtering the mixture through a 100-mesh stainless steel screen to obtain liquid medicine c.
Step five: concentrating the liquid medicine c in a concentration tank to a relative specific gravity of 1.180-1.200g/ml, and filtering with a 230-mesh stainless steel filter screen to obtain liquid medicine d.
Step six: and adding one or more of pectin, EGCG, xylitol and edible essence into the liquid medicine d, and mixing and stirring for 15 minutes to obtain a mixture e.
Step seven: and (3) putting the mixture e into a drying box, setting the temperature to be 50-60 ℃, and keeping the water content to be less than 10% after 12 hours to obtain a mixture f.
Step eight: and (3) placing the mixture f into an ultramicro crusher, and crushing the mixture f into particles g with the particle size of less than 0.01 micrometer.
Step nine: and (3) carrying out microwave irradiation heating on the particles g to promote the oil-containing cells to be fully cracked, so that the water content of the oil-containing cells is reduced to 6%.
Step ten: and granulating the irradiated granules g, bagging and sealing to obtain the radiation-resistant granules.
Example 3:
the Chinese herbal medicine for adjuvant therapy of diabetes is characterized by comprising the following raw materials in parts by weight: 38 parts of pseudo-ginseng stem leaves, 14 parts of gardenia fruits, 2 parts of wolfberry fruits, 2 parts of rhizoma polygonati, 3 parts of lotus leaves, 3 parts of mulberry leaves, 14 parts of kudzu roots and 19 parts of tartary buckwheat.
The Chinese herbal medicine for adjuvant therapy of diabetes and the preparation method thereof are characterized in that the preparation method comprises the following steps:
the method comprises the following steps: weighing the raw materials according to the formula in a given proportion, pouring the raw materials into a boiling and extracting pot, and adding 9 times of purified water.
Step two: boiling with strong fire, decocting with slow fire for 2 hr, and filtering to obtain medicinal liquid a.
Step three: adding 9 times of purified water into the residue, boiling, decocting with slow fire for 2 hr, and filtering to obtain medicinal liquid b.
Step four: mixing the liquid medicine a and the liquid medicine b, and filtering the mixture through a 100-mesh stainless steel screen to obtain liquid medicine c.
Step five: concentrating the liquid medicine c in a concentration tank to a relative specific gravity of 1.180-1.200g/ml, and filtering with a 230-mesh stainless steel filter screen to obtain liquid medicine d.
Step six: and adding one or more of pectin, EGCG, xylitol and edible essence into the liquid medicine d, and mixing and stirring for 15 minutes to obtain a mixture e.
Step seven: and (3) putting the mixture e into a drying box, setting the temperature to be 50-60 ℃, and keeping the water content to be less than 10% after 12 hours to obtain a mixture f.
Step eight: and (3) placing the mixture f into an ultramicro crusher, and crushing the mixture f into particles g with the particle size of less than 0.01 micrometer.
Step nine: and (3) carrying out microwave irradiation heating on the particles g to promote the oil-containing cells to be fully cracked, so that the water content of the oil-containing cells is reduced to 6%.
Step ten: and granulating the irradiated granules g, bagging and sealing to obtain the radiation-resistant granules.
The stem and leaf of pseudo-ginseng has the effects of reducing blood fat, resisting inflammation and delaying senility. The record of the compendium of materia Medica is Shi Yi: ginseng, radix Ginseng and Notoginseng are the most valuable Chinese herbs, because it tonifies qi the first time and tonifies blood the first time, and its flavor is the same and powerful. "; the gardenia fruits are bitter in taste and cold in nature, and have the effects of purging fire, relieving restlessness, clearing heat, promoting diuresis, cooling blood and detoxifying; the medlar has the effects of regulating blood fat, reducing blood sugar, reducing blood pressure and protecting liver. The compendium of materia Medica records: medlar, sweet in nature and taste, neutral in nature and flavor. It enters liver and kidney meridians. Has the functions of supplementing qi and nourishing yin, nourishing liver and kidney, and benefiting essence and improving eyesight; rhizoma Polygonati is sweet in taste and neutral in nature, and has effects of invigorating spleen, moistening lung, invigorating qi and nourishing yin. The Shenxianziao Jing records the functions of rhizoma polygonati as follows: to strengthen the middle energizer and replenish qi, harmonize the five zang organs and enrich the muscles. "; lotus leaf, bitter and astringent in flavor, is neutral and enters liver, spleen, stomach and heart meridians. Has effects in clearing summer-heat, promoting diuresis, invigorating hair, clearing yang, cooling blood, and stopping bleeding; mulberry leaf, bitter and sweet in taste and cold in nature. Has effects of dispelling pathogenic wind and heat, clearing lung-heat, moistening dryness, suppressing hyperactive liver, improving eyesight, cooling blood, and stopping bleeding. The book Ben Cao fen Jing (the materia Medica of materia Medica): bitter, sweet and cool. Nourish dryness and cool blood, stop bleeding and dispel wind, clear and purge qi heat of shaoyang. "; kudzuvine root, sweet and pungent in flavor, cool in nature. Has the effects of expelling pathogenic factors from muscles, relieving fever, promoting eruption, promoting salivation, quenching thirst, invigorating yang, and relieving diarrhea. The book Jing: diabetes, fever, vomiting, various kinds of arthralgia, yin qi generation and toxin expelling; the tartary buckwheat has the effects of regulating blood sugar and blood fat, protecting the liver, resisting oxidation and resisting tumors. Recorded in compendium of materia medica, tartary buckwheat is bitter in taste and neutral in nature and cold, and can strengthen intestines and stomach, tonify qi, keep spirit, benefit ears and eyes, and refine five internal organs and dregs. Tartary buckwheat is recorded in Qianjin Yao Fang, Chinese medicine dictionary and related documents, and has the effects of soothing the nerves, activating qi and blood, lowering qi, widening the intestines, clearing away heat, swelling and pain, removing stagnation, clearing away the bowels, moistening the intestines, relaxing the bowels, relieving cough, relieving asthma, resisting inflammation, resisting allergy, strengthening the heart, losing weight, beautifying and the like.
In the invention, the Chinese herbal medicine has the functions of resisting oxidation and enhancing human immunity by adding the tartary buckwheat; the tartary buckwheat can effectively reduce hypertension, hyperlipidemia and hyperglycemia; can remove in vivo waste, improve heart and brain circulation, relieve fatigue, and recover energy; the tartary buckwheat contains a large amount of coarse grain dietary fibers, so that the antioxidation function of the skin can be increased, the skin is healthy and glossy, and the beauty is maintained; the buckwheat flavone contained in the buckwheat can effectively prevent and treat diabetes; the tartary buckwheat contains rare coarse food grain dietary fiber, so that the distribution of gastrointestinal nutrition can be balanced, and constipation can be effectively treated; through adding auxiliary materials, the liquid medicine is easily prepared into decoction, granules, tablets, pills, capsules or dripping pills, and the required preparation types are prepared according to the requirements of users; the oil-containing cells are promoted to be fully cracked by microwave irradiation heating, so that the water content of the oil-containing cells is reduced to 6 percent, the drug property is improved, and the possibility of overdue drugs is reduced; the compatibility of the components of the Chinese herbal medicines is utilized to effectively activate the inert insulin, so that the inert insulin recovers the activity and participates in the normal glycometabolism process; the raw materials are rich, and the health-care tea has the effects of tonifying qi, nourishing yin, reducing blood sugar, regulating lipid, reducing blood pressure, and promoting blood circulation to remove blood stasis; compared with other Chinese herbal medicines in the prior art, the Chinese herbal medicine has a simple formula, does not contain rare medicines, has low cost and can greatly reduce the economic burden of patients and families.
The above description is only for the preferred embodiment of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art should be considered to be within the technical scope of the present invention, and the technical solutions and the inventive concepts thereof according to the present invention should be equivalent or changed within the scope of the present invention.
Claims (10)
1. The Chinese herbal medicine for adjuvant therapy of diabetes is characterized by comprising the following raw materials in parts by weight: 31-45 parts of pseudo-ginseng stem leaves, 7-21 parts of gardenia fruits, 0.5-4 parts of wolfberry fruits, 0.5-4 parts of rhizoma polygonati, 1-7 parts of lotus leaves, 1-6.5 parts of mulberry leaves, 7-21 parts of kudzu roots and 12-26 parts of tartary buckwheat.
2. The Chinese herbal medicine for adjuvant therapy of diabetes mellitus according to claim 1, is characterized by comprising the following raw materials in parts by weight: 36-40 parts of pseudo-ginseng stem leaves, 12-16 parts of gardenia fruits, 1-3 parts of wolfberry fruits, 1-3 parts of rhizoma polygonati, 2-4 parts of lotus leaves, 2-4 parts of mulberry leaves, 12-16 parts of kudzu roots and 17-21 parts of tartary buckwheat.
3. The Chinese herbal medicine for adjuvant therapy of diabetes mellitus according to claim 1, is characterized by comprising the following raw materials in parts by weight: 38 parts of pseudo-ginseng stem leaves, 14 parts of gardenia fruits, 2 parts of wolfberry fruits, 2 parts of rhizoma polygonati, 3 parts of lotus leaves, 3 parts of mulberry leaves, 14 parts of kudzu roots and 19 parts of tartary buckwheat.
4. The Chinese herbal medicine for adjuvant therapy of diabetes mellitus and the preparation method thereof according to claim 1 are characterized in that the preparation method comprises the following steps:
the method comprises the following steps: weighing the raw materials according to a given proportion, pouring the raw materials into a boiling and extracting pot, and adding purified water with the weight 6-12 times of that of the medicinal materials.
Step two: boiling with strong fire, decocting with slow fire for 0.5-5 hr, and filtering to obtain medicinal liquid a.
Step three: adding 6-12 times of purified water into the residue, boiling, decocting with slow fire for 0.5-5 hr, and filtering to obtain medicinal liquid b.
Step four: mixing the liquid medicine a and the liquid medicine b, and filtering the mixture through a 100-mesh stainless steel screen to obtain liquid medicine c.
Step five: concentrating the liquid medicine c in a concentration tank to a relative specific gravity of 1.10-1.30g/ml, and filtering with a 230-mesh stainless steel filter screen to obtain liquid medicine d.
Step six: and adding auxiliary materials into the liquid medicine d, mixing and stirring for 15 minutes to obtain a mixture e.
Step seven: and (3) putting the mixture e into a drying box, setting the temperature to be 50-60 ℃, and keeping the water content to be less than 10% after 12 hours to obtain a mixture f.
Step eight: and (3) placing the mixture f into an ultramicro crusher, and crushing the mixture f into particles g with the particle size of less than 0.1 micrometer.
Step nine: and (3) carrying out microwave irradiation heating on the particles g to promote the oil-containing cells to be fully cracked and reduce the water content to 4-8%.
Step ten: and granulating the irradiated granules g, bagging and sealing to obtain the radiation-resistant granules.
5. The Chinese herbal medicine for adjuvant therapy of diabetes mellitus and the preparation method thereof according to claim 1, characterized in that purified water with 9 times of the amount of the medicinal materials is added in the first step and the third step.
6. The Chinese herbal medicine for adjuvant therapy of diabetes mellitus and the preparation method thereof as claimed in claim 1, wherein the second step and the third step are decocted with slow fire for 2 hours.
7. The Chinese herbal medicine for adjuvant therapy of diabetes mellitus and the preparation method thereof as claimed in claim 1, wherein the Chinese herbal medicine liquid c in the fifth step is concentrated to a relative specific gravity of 1.180-1.200 g/ml.
8. The Chinese herbal medicine for adjuvant therapy of diabetes mellitus and the preparation method thereof as claimed in claim 1, wherein the adjuvant in the sixth step is one or more of pectin, EGCG, xylitol and edible essence.
9. The herb medicine for the adjuvant treatment of diabetes mellitus of claim 1, wherein in step eight the mixture f is micronized to particles g with a particle size of about 0.01 μm.
10. The Chinese herbal medicine for adjuvant therapy of diabetes mellitus and the preparation method thereof as claimed in claim 1, wherein in the ninth step, the water content is reduced to 6%.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910381969.0A CN111686194A (en) | 2019-05-09 | 2019-05-09 | Chinese herbal medicine for adjuvant therapy of diabetes and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910381969.0A CN111686194A (en) | 2019-05-09 | 2019-05-09 | Chinese herbal medicine for adjuvant therapy of diabetes and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111686194A true CN111686194A (en) | 2020-09-22 |
Family
ID=72476018
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910381969.0A Pending CN111686194A (en) | 2019-05-09 | 2019-05-09 | Chinese herbal medicine for adjuvant therapy of diabetes and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111686194A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111643641A (en) * | 2020-07-08 | 2020-09-11 | 上海中医药大学 | Food therapy formula for clearing heat, invigorating spleen and tonifying kidney and preparation method and application thereof |
CN113197257A (en) * | 2021-05-08 | 2021-08-03 | 赵之钦 | Health tea for type 2 diabetes |
-
2019
- 2019-05-09 CN CN201910381969.0A patent/CN111686194A/en active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111643641A (en) * | 2020-07-08 | 2020-09-11 | 上海中医药大学 | Food therapy formula for clearing heat, invigorating spleen and tonifying kidney and preparation method and application thereof |
CN111643641B (en) * | 2020-07-08 | 2022-02-11 | 上海中医药大学 | Food therapy formula for clearing heat, invigorating spleen and tonifying kidney and preparation method and application thereof |
CN113197257A (en) * | 2021-05-08 | 2021-08-03 | 赵之钦 | Health tea for type 2 diabetes |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103656557A (en) | Traditional Chinese medicine composition for strengthening brain and soothing nerves and preparation method thereof | |
CN101518595A (en) | Medical composition with functions of lowering lipid, reducing fat and oxidation resistance and preparation method thereof | |
CN110170009B (en) | Traditional Chinese medicine formula for dispelling effects of alcohol and protecting liver, formula extract and preparation method and application thereof | |
CN105285260A (en) | Anti-alcoholism health tea | |
CN113995788A (en) | Composition for protecting liver and preparation process thereof | |
CN111686194A (en) | Chinese herbal medicine for adjuvant therapy of diabetes and preparation method thereof | |
CN104474472B (en) | Buccal lozenge of lectuce tea and its production method with three high drop effect | |
CN101698026B (en) | Method for producing traditional Chinese medicine formula for treating eye disease of amblyopia | |
CN104922299A (en) | Traditional Chinese medicine healthcare oral liquid used for preventing and treating diabetic retinopathy | |
CN101011562A (en) | Novel formulation of shenqiwendan decoction and production method thereof | |
CN104431195A (en) | Heat clearing type herbal tea and preparation method thereof | |
CN101129638A (en) | Health care medicinal liquor | |
CN106109521A (en) | A kind of Radix Notoginseng oral liquid | |
CN105796753A (en) | Hepatoprotection traditional Chinese medicine composition and preparation method thereof | |
CN115089661A (en) | Application of ginseng composition for assisting in regulating endocrine metabolism and resisting and preventing cancer | |
CN105995711A (en) | Fructus phyllanthi compound preparation and preparation method thereof | |
AU2020101678A4 (en) | A health care drink and preparation method thereof | |
CN111888431A (en) | Composition for treating diabetes and preparation method thereof | |
CN110882362A (en) | Traditional Chinese medicine food therapy product for conditioning diabetes and preparation method thereof | |
CN105168892A (en) | Chinese herbal preparation for treating hypoglycemia and preparing method of Chinese herbal preparation | |
CN103798472A (en) | Healthcare tea and healthcare life-maintaining preparation | |
CN111388604B (en) | Traditional Chinese medicine composition for treating migraine and preparation method thereof | |
CN111686196A (en) | Traditional Chinese medicine composition for improving immunity and preparation method thereof | |
CN107149627A (en) | Compound Chinese medicinal preparation and preparation method for treating yin-yang deficiency Anemia disease | |
CN106954704A (en) | A kind of Dealcoholic liver-protecting tea |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |